BASILEA RECEIVES ADDITIONAL USD 5.4 MILLION FROM BARDA TO CONTINUE DEVELOPMENT OF NOVEL ANTIBIOTIC CEFTIBUTEN-LEDABORBACTAM

Reuters · 2d ago

Please log in to view news